Human papilloma virus (HPV) prophylactic vaccination: Challenges for public health and implications for screening

This publication has 22 references indexed in Scilit:

• Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors
  British Journal of Cancer, 2006
• Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
  The Lancet Oncology, 2005
• Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
  The Lancet, 2004
• The cervical cancer epidemic that screening has prevented in the UK
  The Lancet, 2004
• Cervical Screening in the National Breast and Cervical Cancer Early Detection Program, 1995–2001
  Obstetrics & Gynecology, 2004
• Benefit of cervical screening at different ages: evidence from the UK audit of screening histories
  British Journal of Cancer, 2003
• The causal relation between human papillomavirus and cervical cancer
  Journal of Clinical Pathology, 2002
• Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix
  Cancer, 2001
• Can glandular lesions be diagnosed in pap smear cytology?
  Diagnostic Cytopathology, 2000
• Accuracy of the Papanicolaou Test in Screening for and Follow-up of Cervical Cytologic Abnormalities
  Annals of Internal Medicine, 2000